DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
All Clinical Trials for Brevibloc Double Strength In Plastic Container
| Trial ID |
Title |
Status |
Sponsor |
Phase |
Start Date |
Summary |
| NCT01114971 ↗ |
Labetalol and Esmolol: Vital Signs and Post Operative Pain Management |
Recruiting |
Cedars-Sinai Medical Center |
Phase 4 |
2009-09-01 |
This study proposes to investigate the effects of labetalol or esmolol on managing the vital
signs (like blood pressure and heart rate) during surgery, on pain management, and on the
later recovery after surgery.
It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery.
|
| NCT01179113 ↗ |
Esmolol Infusion During Laminectomy: Effect on Quality of Recovery |
Terminated |
Cedars-Sinai Medical Center |
Phase 4 |
2011-06-01 |
The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly
administered during surgery to help control blood pressure and heart rate, on postoperative
pain levels and requirements for pain medication.
|
| NCT01208402 ↗ |
Esmolol for Treatment of Perioperative Tachycardia |
Terminated |
Baxter Healthcare Corporation |
Phase 3 |
2010-09-01 |
The purpose of this study is to find out if Esmolol is a safe and effective alternative
treatment compared to standard treatment using a long acting beta blocker drug, in
controlling abnormal heart rate before, during and immediately after surgery.
|
| NCT01208402 ↗ |
Esmolol for Treatment of Perioperative Tachycardia |
Terminated |
Duke University |
Phase 3 |
2010-09-01 |
The purpose of this study is to find out if Esmolol is a safe and effective alternative
treatment compared to standard treatment using a long acting beta blocker drug, in
controlling abnormal heart rate before, during and immediately after surgery.
|
| >Trial ID |
>Title |
>Status |
>Phase |
>Start Date |
>Summary |
Clinical Trial Conditions for Brevibloc Double Strength In Plastic Container
Condition Name
| Condition Name for Brevibloc Double Strength In Plastic Container |
| Intervention |
Trials |
| Septic Shock |
3 |
| Myocardial Reperfusion Injury |
1 |
| High-risk, Non-cardiovascular Surgeries |
1 |
| Myocardial Ischemia |
1 |
| [disabled in preview] |
0 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Condition MeSH
| Condition MeSH for Brevibloc Double Strength In Plastic Container |
| Intervention |
Trials |
| Shock, Septic |
3 |
| Shock |
3 |
| Tachycardia |
2 |
| Myocardial Reperfusion Injury |
1 |
| [disabled in preview] |
0 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Clinical Trial Locations for Brevibloc Double Strength In Plastic Container
Trials by Country
| Trials by Country for Brevibloc Double Strength In Plastic Container |
| Location |
Trials |
| United States |
8 |
| Brazil |
6 |
| Turkey |
3 |
| Egypt |
1 |
| France |
1 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Trials by US State
| Trials by US State for Brevibloc Double Strength In Plastic Container |
| Location |
Trials |
| Utah |
2 |
| California |
2 |
| Maryland |
1 |
| Michigan |
1 |
| Ohio |
1 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Clinical Trial Progress for Brevibloc Double Strength In Plastic Container
Clinical Trial Phase
| Clinical Trial Phase for Brevibloc Double Strength In Plastic Container |
| Clinical Trial Phase |
Trials |
| Phase 4 |
7 |
| Phase 3 |
1 |
| Phase 2 |
4 |
| [disabled in preview] |
2 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Clinical Trial Status
| Clinical Trial Status for Brevibloc Double Strength In Plastic Container |
| Clinical Trial Phase |
Trials |
| Recruiting |
7 |
| Unknown status |
3 |
| Terminated |
2 |
| [disabled in preview] |
2 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Clinical Trial Sponsors for Brevibloc Double Strength In Plastic Container
Sponsor Name
| Sponsor Name for Brevibloc Double Strength In Plastic Container |
| Sponsor |
Trials |
| Baxter Healthcare Corporation |
2 |
| Cedars-Sinai Medical Center |
2 |
| Beth Israel Deaconess Medical Center |
2 |
| [disabled in preview] |
2 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Sponsor Type
| Sponsor Type for Brevibloc Double Strength In Plastic Container |
| Sponsor |
Trials |
| Other |
18 |
| Industry |
4 |
| [disabled in preview] |
0 |
This preview shows a limited data set
Subscribe for full access, or try a Trial |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
